Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine in Fibromyalgia Patients With or Without Major Depressive Disorder
NCT00489073Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of duloxetine in fibromyalgia (FM), sponsored by Eli Lilly and Company. Started Nov 2002; status: completed.
02
Drugs
duloxetine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00489073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00489073.